Cargando…
Quantitative approach for cardiac risk assessment and interpretation in tuberculosis drug development
Cardiotoxicity is among the top drug safety concerns, and is of specific interest in tuberculosis, where this is a known or potential adverse event of current and emerging treatment regimens. As there is a need for a tool, beyond the QT interval, to quantify cardiotoxicity early in drug development,...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953981/ https://www.ncbi.nlm.nih.gov/pubmed/29520534 http://dx.doi.org/10.1007/s10928-018-9580-2 |